Zobrazeno 1 - 10
of 5 525
pro vyhledávání: ''
Autor:
Lee M. Jampol, Adam R. Glassman, Michael J. Elman, Andrew N. Antoszyk, Hani Salehi-Had, Wesley T. Beaulieu, Clement C Chow, Jennifer K. Sun, Maureen G. Maguire
Publikováno v:
JAMA Ophthalmol
IMPORTANCE: Although there were no differences in mean visual acuity (VA) over 24 weeks after vitrectomy with panretinal photocoagulation (PRP) vs aflibercept in a randomized clinical trial among eyes with vitreous hemorrhage due to proliferative dia
Autor:
Jennifer I. Lim
Publikováno v:
JAMA Ophthalmology.
Autor:
Yenchieh Cheng, David M. Brown, Andres Emanuelli, Charles C. Wykoff, Jeffrey S. Heier, Karen Chu, W. Lloyd Clark, Alyson J. Berliner, David S. Boyer, David M. Weinreich, Patrick M. Higgins, Michael C. Singer, George D. Yancopoulos, Kimberly Reed, Robert Vitti
Publikováno v:
JAMA Ophthalmol
IMPORTANCE: Proactive treatment of nonproliferative diabetic retinopathy (NPDR) reduces the risk of progression to vision-threatening complications. OBJECTIVE: To evaluate vascular endothelial growth factor blockade therapy with intravitreal afliberc
Publikováno v:
JAMA Internal Medicine. 181:1043
Importance In the treatment of type 2 diabetes, evidence of the comparative effectiveness of sodium-glucose cotransporter 2 (SGLT2) inhibitors vs sulfonylureas—the second most widely used antihyperglycemic class after metformin—is lacking. Object
Publikováno v:
JAMA Ophthalmology. 139:908
Autor:
Prashant Durgapal, Divya Chandrasekaran, Neirita Hazarika, Vishal Gupta, Sanjeev Kishore, Riti Bhatia
Publikováno v:
JAMA Dermatology. 157:1002
Autor:
Gail D'Onofrio, Andrew J. Saxon, Aidan A. Vosooghi, Erik Anderson, Xiwen Zhao, Kathryn Hawk, Andrew A. Herring, Joshua Luftig, James Dziura, Ryan P. McCormack
Publikováno v:
JAMA Network Open
Key Points Question Is high-dose (>12 mg) buprenorphine induction safe and well tolerated in patients with untreated opioid use disorder who present to the emergency department? Findings In this case series of 579 cases, 54 clinicians followed a high
Autor:
Weifeng Weng, Michael L. Barnett, Jonathan L. Vandergrift, Bradley M. Gray, Rebecca S. Lipner
Publikováno v:
JAMA Network Open
This cross-sectional study compares the association of clinical knowledge with opioid prescribing from 2009 to 2011 when prescribing peaked nationally with 2015 to 2017 when guidelines shifted away from opioid prescribing.
Key Points Question Is
Key Points Question Is
Publikováno v:
JAMA Internal Medicine. 181:850
Autor:
Matthew S. Robbins
Publikováno v:
JAMA. 325:1874
Importance Approximately 90% of people in the US experience headache during their lifetime. Migraine is the second leading cause of years lived with disability worldwide. Observations Primary headache disorders are defined as headaches that are unrel